C. Ward (Newcastle-Upon-Tyne, United Kingdom), E. Verschuuren (Groningen, The Netherlands)
Late-breaking abstract: Non specific IgG replacement in lung transplantation recipients with low IgG plasma levels: Effects on survival and bronchiolitis obliterans syndrome occurrence
C. Pison, M. France, H. Roth, C. Saint Raymond, J. Claustre, B. Camara, S. Quétant, Grenoble Lung Transplantation Group (Grenoble, France)
|  |
Significance of anti-HLA immunization in lung transplantation
J. Reeb, P. E. Falcoz, N. Santelmo, Z. Mansour, A. C. Lejay, S. Renaud, A. Parissiadis, D. Hanau, R. Kessler, G. Massard (Strasbourg, France)
|  |
Effect of cyclosporine A in ex vivo reperfused pig lungs
S. Gennai, M. Maignan, A. Brouta, R. Briot (Grenoble, La Tronche, France)
|  |
Comparison between SCOT-15® and Perfadex® as lung preservation solutions
A. Olland, C. Meers, M. Benahmed, K. Elbayed, S. Wauters, E. Verbeken, G. Verleden, I. Namer, D. Van Raemdonck (Leuven, Belgium; Strasbourg, France)
| |
MSK1 kinase in obliterative bronchiolitis after heterotopic tracheal transplantation
S. Nemska, F. Daubeuf, L. Reber, N. Frossard (Illkirch, France)
| |
Development of a novel model of obliterative bronchiolitis following orthotopic lung transplantation in the rat
M. Vadori, F. Lunardi, D. Arben, A. De Filippis, E. Cozzi, F. Rea, F. Calabrese (Padua, Italy)
| |
A new mouse model of bronchiolitis obliterans syndrome
A. Vaneylen, S. De Vleeschauwer, W. Jungraithmayr, S. Wauters, S. Willems, S. Verleden, A. Willems-Widyastuti, B. Vanaudenaerde, D. Van Raemdonck, E. Verbeken, G. Verleden (Leuven, Belgium; Zurich, Switzerland)
| |